Biochemical Biomarkers and Neurodegenerative Diseases
In this book, we collected scientific articles, including reviews and research articles, showcasing the lastest literature on the importance of biochemical biomarkers in the management of neurodegenerative diseases, from screening to diagnosis, prognosis, and treatment.
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2021 |
Language: | English |
Physical Description: | 1 electronic resource (156 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 03047nam-a2200985z--4500 | ||
---|---|---|---|
001 | 993546310204498 | ||
005 | 20240612213351.0 | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 202201s2021 xx |||||o ||| 0|eng d | ||
035 | |a (CKB)5400000000042281 | ||
035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/76661 | ||
035 | |a (EXLCZ)995400000000042281 | ||
041 | 0 | |a eng | |
100 | 1 | |a Ciaccio, Marcello |4 edt | |
245 | 1 | 0 | |a Biochemical Biomarkers and Neurodegenerative Diseases |
260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
300 | |a 1 electronic resource (156 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | |a Open access |f Unrestricted online access |2 star | ||
520 | |a In this book, we collected scientific articles, including reviews and research articles, showcasing the lastest literature on the importance of biochemical biomarkers in the management of neurodegenerative diseases, from screening to diagnosis, prognosis, and treatment. | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
650 | 7 | |a Neurosciences |2 bicssc | |
653 | |a GLUT3 | ||
653 | |a cerebral ischemia | ||
653 | |a MCAO | ||
653 | |a resveratrol | ||
653 | |a astrocytes | ||
653 | |a AMPK | ||
653 | |a amyotrophic lateral sclerosis | ||
653 | |a GSK3β | ||
653 | |a neurodegenerative disease | ||
653 | |a PD | ||
653 | |a Arylsulfatase A | ||
653 | |a lysosomes | ||
653 | |a GWAS | ||
653 | |a Gaucher's disease | ||
653 | |a prognostic biomarker | ||
653 | |a focused ultrasound | ||
653 | |a MR-guided focused ultrasound | ||
653 | |a high-intensity focused ultrasound ablation | ||
653 | |a magnetic resonance imaging | ||
653 | |a image quality | ||
653 | |a stereotaxic techniques | ||
653 | |a essential tremor | ||
653 | |a Alzheimer's disease | ||
653 | |a amyloid precursor protein | ||
653 | |a Tyr682 residue | ||
653 | |a YENPTY motif | ||
653 | |a Fyn tyrosine kinase | ||
653 | |a amyloid beta | ||
653 | |a ALS | ||
653 | |a biomarker | ||
653 | |a beta amyloid | ||
653 | |a AD | ||
653 | |a biomarkers | ||
653 | |a SARS-CoV-2 | ||
653 | |a neuroinflammation | ||
653 | |a neurodegenerative nisease | ||
653 | |a nervous system | ||
653 | |a Alzheimer's Disease | ||
653 | |a Vitamin D | ||
653 | |a 25(OH)D levels | ||
653 | |a Vitamin D deficiency | ||
653 | |a inherited neuromuscular disorders | ||
653 | |a rare diseases | ||
653 | |a multiple sclerosis | ||
653 | |a genetic | ||
653 | |a polymorphisms | ||
653 | |a FOXP3 | ||
653 | |a GATA3 | ||
653 | |a vitamin D | ||
653 | |a neuromelanin | ||
653 | |a nigrosome-1 | ||
653 | |a iron | ||
653 | |a radiomics | ||
653 | |a neurodegenerative diseases | ||
653 | |a Parkinson's disease | ||
653 | |a parkinsonian disorders | ||
776 | |z 3-0365-1722-7 | ||
776 | |z 3-0365-1721-9 | ||
700 | 1 | |a Ciaccio, Marcello |4 oth | |
906 | |a BOOK | ||
ADM | |b 2024-06-13 00:38:35 Europe/Vienna |f system |c marc21 |a 2022-04-04 09:22:53 Europe/Vienna |g false | ||
AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338165620004498&Force_direct=true |Z 5338165620004498 |b Available |8 5338165620004498 |